U.S. Food and Drug Administration • Center for Drug Evaluation and ResearchSkip navigation
CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - April 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP 120 MG, 180 MG, 240 MG, 300 MG, AND 360 MG (ONCE-A-DAY DOSAGE) ANDRX PHARMACEUTICALS, L.L.P. TIAZAC EXTENDED-RELEASE CAPSULES 4/10/2003 
2 HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS 7.5 MG/200 MG TEVA PHARMACEUTICALS USA VICOPROFEN TABLETS 4/11/2003 
3 DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP EQ. TO 10 MG DEXAMETHASONE PHOSPHATE/ML (PRESERVATIVE-FREE) AMERICAN PHARMACEUTICAL PARTNERS, INC. DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP 4/11/2003 
4 MINOCYCLINE HYDROCHLORIDE TABLETS, USP 50 MG (BASE), 75 MG (BASE), AND 100 MG (BASE) PAR PHARMACEUTICAL, INC. MINOCIN TABLETS 4/16/2003 
5 NAPROXEN SODIUM EXTENDED-RELEASE TABLETS 375 MG (BASE) ANDRX PHARMACEUTICALS, LLC NAPRELAN EXTENDED-RELEASE TABLETS 4/23/2003 
6 CARBINOXAMINE MALEATE ORAL SOLUTION 4 MG/5 ML MIKART, INC. CLISTIN ELIXIR 4/25/2003 
7 DIHYDROERGOTAMINE MESYLATE INJECTION, USP 1 MG/ML; SINGLE-DOSE AMPULES PADDOCK LABORATORIES, INC. D.H.E. 45 INJECTION 4/28/2003 

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: May 1, 2003
Originator: OTCOM/OGD
HTML by SJW